JUN, TLR4 (42), EGFR (43), and TNF (44) were confirmed to promote the progression of NAFLD in previous studies, while ANXA5 (45) and PTEN (46) were identified as protective factors. Here, EGFR is linked to metabolic dysfunction-associated steatotic liver disease.